Published in PLoS Comput Biol on September 01, 2007
Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell (2012) 3.39
The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol (2014) 2.99
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J (2009) 2.09
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev (2010) 1.62
Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci U S A (2008) 1.56
Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers. Mol Neurodegener (2010) 1.34
Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation. Proc Natl Acad Sci U S A (2009) 1.21
The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity. J Mol Biol (2010) 1.07
A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates. PLoS Comput Biol (2008) 1.02
Contrasting disease and nondisease protein aggregation by molecular simulation. Acc Chem Res (2008) 1.01
Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide. Biophys J (2010) 0.99
Formation and growth of oligomers: a Monte Carlo study of an amyloid tau fragment. PLoS Comput Biol (2008) 0.99
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol (2013) 0.97
Thermodynamic selection of steric zipper patterns in the amyloid cross-beta spine. PLoS Comput Biol (2009) 0.96
Extending the PRIME model for protein aggregation to all 20 amino acids. Proteins (2010) 0.96
Amyloid-β oligomers are sequestered by both intracellular and extracellular chaperones. Biochemistry (2012) 0.96
Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange. Biophys J (2009) 0.95
9,10-Anthraquinone hinders beta-aggregation: how does a small molecule interfere with Abeta-peptide amyloid fibrillation? Protein Sci (2009) 0.94
A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation. PLoS Comput Biol (2009) 0.94
Advances in ion mobility spectrometry-mass spectrometry reveal key insights into amyloid assembly. Biochim Biophys Acta (2012) 0.94
Protein Folding and Mechanisms of Proteostasis. Int J Mol Sci (2015) 0.93
Role of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25-35) peptide. Biophys J (2012) 0.91
Amyloidogenesis abolished by proline substitutions but enhanced by lipid binding. PLoS Comput Biol (2009) 0.91
Spontaneous formation of twisted Aβ(16-22) fibrils in large-scale molecular-dynamics simulations. Biophys J (2011) 0.90
Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products. PLoS One (2010) 0.90
Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology. ACS Chem Neurosci (2010) 0.89
Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding. Proteins (2009) 0.89
Polymorphic structures of Alzheimer's β-amyloid globulomers. PLoS One (2011) 0.89
Disordered flanks prevent peptide aggregation. PLoS Comput Biol (2008) 0.89
An effective all-atom potential for proteins. PMC Biophys (2009) 0.89
Granular assembly of alpha-synuclein leading to the accelerated amyloid fibril formation with shear stress. PLoS One (2009) 0.89
Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2008) 0.88
Insights into stability and toxicity of amyloid-like oligomers by replica exchange molecular dynamics analyses. Biophys J (2008) 0.87
All-atom computer simulations of amyloid fibrils disaggregation. Biophys J (2008) 0.86
Mapping the conformational dynamics and pathways of spontaneous steric zipper Peptide oligomerization. PLoS One (2011) 0.82
Kinetics of amyloid aggregation: a study of the GNNQQNY prion sequence. PLoS Comput Biol (2012) 0.79
When amyloids become prions. Prion (2014) 0.79
Early amyloidogenic oligomerization studied through fluorescence lifetime correlation spectroscopy. Int J Mol Sci (2012) 0.79
Exploring the accessible conformations of N-terminal acetylated α-synuclein. FEBS Lett (2013) 0.79
Crystal structure of a conformation-dependent rabbit IgG Fab specific for amyloid prefibrillar oligomers. Biochim Biophys Acta (2012) 0.79
Structural determination of Abeta25-35 micelles by molecular dynamics simulations. Biophys J (2010) 0.78
Influence of temperature on formation of perfect tau fragment fibrils using PRIME20/DMD simulations. Protein Sci (2012) 0.78
A simple lattice model that captures protein folding, aggregation and amyloid formation. PLoS One (2014) 0.77
Direct observations of shifts in the β-sheet register of a protein-peptide complex using explicit solvent simulations. Biophys J (2011) 0.76
Structural transitions and oligomerization along polyalanine fibril formation pathways from computer simulations. Proteins (2012) 0.76
β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides. PLoS One (2014) 0.76
Factor V activator from Daboia russelli russelli venom destabilizes β-amyloid aggregate, the hallmark of Alzheimer disease. J Biol Chem (2013) 0.76
Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau. Proc Natl Acad Sci U S A (2015) 0.76
Structural diversity and initial oligomerization of PrP106-126 studied by replica-exchange and conventional molecular dynamics simulations. PLoS One (2014) 0.76
Reduced atomic pair-interaction design (RAPID) model for simulations of proteins. J Chem Phys (2013) 0.76
Does amino acid sequence determine the properties of Aβ dimer? J Chem Phys (2011) 0.76
Self-Assembly of Aβ40, Aβ42 and Aβ43 Peptides in Aqueous Mixtures of Fluorinated Alcohols. PLoS One (2015) 0.75
Impact of sequence on the molecular assembly of short amyloid peptides. Proteins (2014) 0.75
Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure. Biochim Biophys Acta (2015) 0.75
Unique Properties of the Rabbit Prion Protein Oligomer. PLoS One (2016) 0.75
A minimal conformational switching-dependent model for amyloid self-assembly. Sci Rep (2016) 0.75
Two-Step Amyloid Aggregation: Sequential Lag Phase Intermediates. Sci Rep (2017) 0.75
Finite size effects in simulations of protein aggregation. PLoS One (2008) 0.75
Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein. J Mol Model (2014) 0.75
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Protein folding and misfolding. Nature (2003) 14.92
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci (2004) 9.73
Protein misfolding, evolution and disease. Trends Biochem Sci (1999) 7.73
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16
Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science (2000) 6.16
Folding proteins in fatal ways. Nature (2003) 5.58
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46
The most infectious prion protein particles. Nature (2005) 5.37
Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem (1997) 5.07
Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A (2003) 4.80
Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol (1997) 4.16
A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature (2006) 3.76
Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry (2000) 3.65
100 years and counting: prospects for defeating Alzheimer's disease. Science (2006) 3.24
Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. Structure (2003) 3.18
Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol (1997) 3.05
Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol (2003) 2.85
Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem (2001) 2.77
Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans (2002) 2.55
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys (2006) 2.47
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry (2000) 2.37
Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem (1996) 2.34
Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci U S A (2004) 2.18
Monomer adds to preformed structured oligomers of Abeta-peptides by a two-stage dock-lock mechanism. Proc Natl Acad Sci U S A (2006) 2.01
Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. J Mol Biol (2005) 1.99
Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci (2006) 1.89
The folding thermodynamics and kinetics of crambin using an all-atom Monte Carlo simulation. J Mol Biol (2001) 1.86
Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. Acc Chem Res (2006) 1.80
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr Opin Chem Biol (2006) 1.70
Molecular dynamics simulation of amyloid beta dimer formation. Biophys J (2004) 1.63
Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol (2006) 1.58
Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci U S A (2004) 1.52
Numerical evidence for bcc ordering at the surface of a critical fcc nucleus. Phys Rev Lett (1995) 1.34
Experimental evidence for the reorganization of beta-strands within aggregates of the Abeta(16-22) peptide. J Am Chem Soc (2005) 1.26
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J (2005) 1.25
Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. J Am Chem Soc (2007) 1.23
Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol (2005) 1.19
PROFASI: A Monte Carlo simulation package for protein folding and aggregation. J Comput Chem (2006) 1.18
Molecular origin of polyglutamine aggregation in neurodegenerative diseases. PLoS Comput Biol (2005) 1.17
Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J (2004) 1.16
Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. Biochemistry (2000) 1.13
Folding thermodynamics of peptides. Biophys J (2004) 1.10
Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation. J Mol Biol (2006) 1.09
Conformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregation. Protein Sci (2001) 1.06
Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. Appl Environ Microbiol (2006) 1.04
Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations. J Mol Biol (2005) 1.04
In silico assembly of Alzheimer's Abeta16-22 peptide into beta-sheets. J Am Chem Soc (2004) 1.02
Thermodynamics of alpha- and beta-structure formation in proteins. Biophys J (2003) 1.00
Reversal of protein aggregation provides evidence for multiple aggregated States. J Mol Biol (2004) 0.99
Common attributes of native-state structures of proteins, disordered proteins, and amyloid. Proc Natl Acad Sci U S A (2006) 0.97
Folding thermodynamics of three beta-sheet peptides: a model study. Proteins (2004) 0.96
The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett (2007) 0.93
Comparative analysis of the cytotoxicity of homopolymeric amino acids. Biochim Biophys Acta (2005) 0.90
Quantitative prediction of crystal-nucleation rates for spherical colloids: a computational approach. Annu Rev Phys Chem (2004) 0.88
Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J Mol Biol (2006) 0.87
Aggregating the amyloid Abeta(11-25) peptide into a four-stranded beta-sheet structure. Proteins (2006) 0.86
Oligomerization process of the hemolytic lectin CEL-III purified from a sea cucumber, Cucumaria echinata. J Biochem (2002) 0.81
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Simultaneous determination of protein structure and dynamics. Nature (2005) 5.28
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) (2003) 5.15
Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature (2003) 4.98
The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci U S A (2002) 4.08
Long-range interactions within a nonnative protein. Science (2002) 4.06
Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell (2011) 3.98
Protein structure determination from NMR chemical shifts. Proc Natl Acad Sci U S A (2007) 3.96
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
Amyloid formation by globular proteins under native conditions. Nat Chem Biol (2009) 3.72
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2004) 3.58
Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell (2012) 3.39
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol (2005) 3.18
Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc (2005) 3.13
Role of intermolecular forces in defining material properties of protein nanofibrils. Science (2007) 2.94
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR. Nature (2004) 2.84
The importance of sequence diversity in the aggregation and evolution of proteins. Nature (2005) 2.70
De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci U S A (2002) 2.59
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J (2002) 2.59
Prediction of aggregation-prone regions in structured proteins. J Mol Biol (2008) 2.56
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A (2006) 2.46
Molecular recycling within amyloid fibrils. Nature (2005) 2.39
Kinetic partitioning of protein folding and aggregation. Nat Struct Biol (2002) 2.37
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol (2007) 2.35
Structure of an intermediate state in protein folding and aggregation. Science (2012) 2.24
Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc Natl Acad Sci U S A (2002) 2.18
Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol (2009) 2.14
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol (2004) 2.14
Relation between native ensembles and experimental structures of proteins. Proc Natl Acad Sci U S A (2006) 2.10
Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci U S A (2003) 1.93
Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci (2006) 1.89
Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci (2007) 1.88
Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry (2012) 1.87
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
The Zyggregator method for predicting protein aggregation propensities. Chem Soc Rev (2008) 1.81
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A (2002) 1.80
The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J (2007) 1.79
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc Natl Acad Sci U S A (2013) 1.75
Fast and accurate predictions of protein NMR chemical shifts from interatomic distances. J Am Chem Soc (2009) 1.75
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc Natl Acad Sci U S A (2010) 1.72
From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol (2012) 1.71
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature (2003) 1.66
The MUMO (minimal under-restraining minimal over-restraining) method for the determination of native state ensembles of proteins. J Biomol NMR (2007) 1.65
Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat Struct Biol (2002) 1.64
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. Structure (2005) 1.63
The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol (2011) 1.62
Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci U S A (2008) 1.56
Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stages. J Mol Biol (2013) 1.56
Exploring amyloid formation by a de novo design. Proc Natl Acad Sci U S A (2004) 1.55
Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMR. J Am Chem Soc (2011) 1.54
Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc (2011) 1.53
Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J Chem Phys (2011) 1.52
Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy. Biochemistry (2010) 1.50
Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (2014) 1.48
Automated assignment of SCOP and CATH protein structure classifications from FSSP scores. Proteins (2002) 1.48
ANS binding reveals common features of cytotoxic amyloid species. ACS Chem Biol (2010) 1.48
Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem (2005) 1.48
Determination of a transition state at atomic resolution from protein engineering data. J Mol Biol (2002) 1.47
A coupled equilibrium shift mechanism in calmodulin-mediated signal transduction. Structure (2008) 1.45
Determination of an ensemble of structures representing the denatured state of the bovine acyl-coenzyme a binding protein. J Am Chem Soc (2004) 1.44
Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci (2004) 1.44
A tensor-free method for the structural and dynamical refinement of proteins using residual dipolar couplings. J Phys Chem B (2014) 1.41
In situ measurements of the formation and morphology of intracellular β-amyloid fibrils by super-resolution fluorescence imaging. J Am Chem Soc (2011) 1.37
Using NMR chemical shifts as structural restraints in molecular dynamics simulations of proteins. Structure (2010) 1.36
The formation of spherulites by amyloid fibrils of bovine insulin. Proc Natl Acad Sci U S A (2004) 1.36
Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J (2002) 1.35
Protein misfolding and disease: from the test tube to the organism. Curr Opin Chem Biol (2008) 1.35
Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7. Proc Natl Acad Sci U S A (2005) 1.31
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31
Heteronuclear NMR investigations of dynamic regions of intact Escherichia coli ribosomes. Proc Natl Acad Sci U S A (2004) 1.31
Structural biology. Dynamic visions of enzymatic reactions. Science (2006) 1.30